Email this page Print this page Was this page helpful?

Pharmacogenomics: Predicting Which Drugs Will Work and Which Won't

Introduction | Benefits | Interpretation | Q's and Concerns | Future | Related Pages
Related Pages

Elsewhere On The Web
National Human Genome Research Institute: DNA Chip Technology Fact Sheet
National Human Genome Research Institute: DNA Microarray Technology
The Pharmacogenomics Journal
Pharmacogenomics From the Ground Up, Session 1: Concepts and Tools in Pharmacogenomics
Genomics at FDA, Background Information on Genomics
Personalized Medicine: What is it? How will it affect health care? 11th Annual FDA Science Forum
FDA Consumer Magazine: Genomics and Personalized Medicine

Article Sources

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Cattaneo, D. et. al. (2004 March 2). From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy. Medscape from Am J Transplant 4(3):299-310, 2004 [On-line journal]. Available online at http://www.medscape.com/viewarticle/470038 through http://www.medscape.com.

(2006 February 27, Modified). Pharmacogenomics. Human Genome Project Information [On-line information]. Available online at http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml through target="_blank>http://www.ornl.gov.

Ma, M. et. al. (2002 December 2). Genetic Basis of Drug Metabolism. Medscape from Am J Health-Syst Pharm 59(21):2061-2069, 2002 [On-line journal]. Available online at http://www.medscape.com/viewarticle/444804 through http://www.medscape.com.

Pharmacogenomics: A Clinician’s Primer on Emerging Technologies for Improved Patient Care. Mayo Communiqué [On-line information]. Available online at http://www.mayoreferenceservices.org/media-comm/apr2002.pdf#search='pharmacogenomics' through http://www.mayoreferenceservices.org.

Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part one. PriceWaterhouseCoopers [On-line information]. Available online at http://www.pwc.com/extweb/execpers.nsf/docid/1FABC5BA1F9A885F85257088006230C1 through http://www.pwc.com.

Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part two. PriceWaterhouseCoopers [On-line information]. Available online at http://www.pwc.com/extweb/execpers.nsf/docid/E918DAA0105A2939852570E00079022E through http://www.pwc.com.

(2003 November 3). FDA Issues Guidance on Pharmacogenomics Data. FDA News [On-line information]. Available online at http://www.fda.gov/bbs/topics/NEWS/2003/NEW00969.html through http://www.fda.gov.

Vega, C. (2004). The AAFP Focuses on Genomics. Highlights of the American Academy of Family Physicians 2004 Scientific Assembly and the 17th World Conference of Family Doctors [On-line CME/CE]. Available online at http://www.medscape.com/viewarticle/495064 through http://www.medscape.com.

Henry, C. and Washington, C&EN (2001 August 13). PHARMACOGENOMICS, Genetic markers such as single-nucleotide polymorphisms may lead to personalized medicines for a wide variety of diseases. Chemical and Engineering News v79 (33) pp 37-42. [On-line journal]. Available online at http://pubs.acs.org/cen/coverstory/7933/7933pharmacogenomics.html through http://pubs.acs.org.

Rauscher, M. (2006). Some People May be Genetically Susceptible to Chronic Fatigue. Reuters Health Information [On-line information]. Available online at http://www.medscape.com/viewarticle/530400_print through http://www.medscape.com.

Hayney, M. (2002 October 9). Pharmacogenomics and Infectious Diseases: Impact on Drug Response and Applications to Disease Management. Medscape from American Journal of Health-System Pharmacy 59(17): 1626-1631 [On-line journal]. Available online at http://www.medscape.com/viewarticle/442071 through http://www.medscape.com.

Norton, R. (2001). Pharmacogenomics and Individualized Drug Therapy. Medscape Pharmacotherapy 3(1), 2001. [On-line information]. Available online at http://www.medscape.com/viewarticle/408606 through http://www.medscape.com.

Khoury, M. and Morris, J. (2006 May 8, Updated). Pharmacogenomics & Public Health: The Promise of Targeted Disease Prevention. CDC, Genomics and Disease Prevention [On-line information]. Available online at http://www.cdc.gov/genomics/training/perspectives/factshts/pharmacofs.htm through http://www.cdc.gov.

Barash, C. (2001). Ethical, Legal, and Social Implications of Genomic Research. Medscape Pharmacotherapy 3(1), 2001 [On-line information]. Available online at http://www.medscape.com/viewarticle/408601 through http://www.medscape.com.

Ross, J. and Ginsburg, G. (2003 February 14). The Integration of Molecular Diagnostics With Therapeutics. Am J Clin Pathol 119(1):26-36, 2003. [On-line information]. Available online at http://www.medscape.com/viewarticle/447846 through http://www.medscape.com.

(2004 May 30, Revised). Microarrays: Chipping Away At The Mysteries Of Science And Medicine. National Center for Biotechnology Information [On-line information]. Available online at http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html through http://www.ncbi.nlm.nih.gov.

Rados, C. (2005 November-December). Genomics and Medical Devices: A New Paradigm for Health Care. FDA Consumer magazine [On-line information]. Available online at http://www.fda.gov/fdac/features/2005/605_devices.html through http://www.fda.gov.

(2004 December 23). FDA Clears First of Kind Genetic Lab Test. FDA News [On-line information]. Available online at http://www.fda.gov/bbs/topics/news/2004/new01149.html through http://www.fda.gov.

(2006 February 9). Draft Guidance for Industry and FDA Staff - Pharmacogenetic Tests and Genetic Tests for Heritable Markers. FDA Center for Devices and Radiological Health [On-line Draft Guidance]. Available online at http://www.fda.gov/cdrh/oivd/guidance/1549.html through http://www.fda.gov.

(2005 August 22). FDA Clears Genetic Test That Advances Personalized Medicine. FDA OVID News Archive [On-line News Release]. Available online at http://www.fda.gov/cdrh/oivd/news.html#042706 through http://www.fda.gov.

Freuh, F. (2005 April 26). Personalized Medicine: What is it? How will it affect health care? 11th Annual FDA Science Forum [On-line presentation]. PDF available for download at http://www.fda.gov/cder/genomics/scienceForum2005.pdf through http://www.fda.gov.

Meadows, M. (2005 November December) Genomics and Personalized Medicine. FDA Consumer Magazine [On-line information]. Available online at http://www.fda.gov/fdac/features/2005/605_genomics.html through http://www.fda.gov.

M. J. Kim, S. M. Huang, F. W. Frueh, A. N. Rahman, Y. M. Choi, K. M. Robie Suh, G. Shashaty, R. Rieves, L. J. Lesko. CDER, FDA, Silver Spring, MD (2006). Risk Management of Warfarin Overanticoagulation: Role of Pharmacogenomic Information. Available online at http://www.cfsan.fda.gov/~frf/forum06/K-16.htm through http://www.cfsan.fda.gov.

M Wadelius, M Piromohamed, (2006). Pharmacogenetics of Warfarin: current status and future challenges. The Pharmacogenomics Journal, 1-13.

« Prev